findmyKOL
Clinical trialNCT07408856Not, yet, recruitingPhase 1Interventional

CAN1012 in Pre-Malignant DCIS and LCIS

SponsorProvidence Health & ServicesEnrollment24Ductal Carcinoma in SituLobular Carcinoma in Situ
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase I/Ib study evaluating CAN1012 in patients with ductal carcinoma in situ and lobular carcinoma in situ.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Providence Portland Cancer Institute - Franz Clinic

    Portland, Oregon, United States

    Alison Conlin, MDAmy Hartman, NPBinbin Zheng, MDBrendan Curti, MDDavid Page, MDJamie Martinez, NPMary Martel, NPMatthew Taylor, MDMolly Davis, NPRaYoung Chung, NPRachel Sanborn, MDRom Leidner, MDRoxanne Griswold, NPRui Li, MD, PhDSasha Stanton, MD, PhD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CAN1012
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2026
Primary completion
31 May 2030
Completion
31 May 2035
Last update posted
23 Jul 2026
Registered enrollment
24
Registry id
NCT07408856
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.